首页> 外文期刊>Medical Mycology Case Reports >Hemophagocytic lymphohistiocytosis (HLH) secondary to disseminated histoplasmosis in the setting of Acquired Immunodeficiency Syndrome (AIDS)
【24h】

Hemophagocytic lymphohistiocytosis (HLH) secondary to disseminated histoplasmosis in the setting of Acquired Immunodeficiency Syndrome (AIDS)

机译:在获得性免疫缺陷综合症(AIDS)中继发于弥漫性组织胞浆病的吞噬性淋巴细胞组织细胞增生症(HLH)

获取原文
       

摘要

Hemophagocytic lymphohistiocytosis (HLH) is a rare and aggressive disease involving immune system over-activation leading to hemophagocytosis. HLH requires early diagnosis and prompt treatment initiation, especially in patients with Acquired Immunodeficiency Syndrome (AIDS). We present a case of a middle-aged male with AIDS and renal failure, who developed HLH secondary to disseminated histoplasmosis. Etoposide chemotherapy as recommended by the HLH 2004 Guidelines was deferred and treatment focused instead on anti-fungal therapy. Anti-retroviral therapy followed thereafter.
机译:噬血细胞淋巴组织细胞增生症(HLH)是一种罕见的侵袭性疾病,涉及免疫系统过度激活导致吞噬细胞增多。 HLH需要早期诊断和迅速的治疗开始,尤其是在获得性免疫缺陷综合症(AIDS)患者中。我们提供了一个患有艾滋病和肾功能衰竭的中年男性病例,该男性继发于弥漫性组织胞浆病而发展为HLH。 HLH 2004指南建议的依托泊苷化学疗法被推迟,而治疗重点改为抗真菌治疗。随后进行抗逆转录病毒疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号